"Executive Summary: Global galectin inhibitor therapeutics market size was valued at USD 187.39 million in 2024 and is projected to reach USD 339.21 million by 2032, with a CAGR of 7.7% during the forecast period of 2025 to 2032. The Galectin Inhibitor Therapeutics Market is experiencing notable growth driven by rising consumer demand, technological innovation, and evolving industry...